- Home
- PHUN vs ORMP Comparison
PHUN vs ORMP Comparison
Compare PHUN & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHUN
- ORMP
- Stock Information
- Founded
- PHUN 2009
- ORMP 2002
- Country
- PHUN United States
- ORMP United States
- Employees
- PHUN N/A
- ORMP N/A
- Industry
- PHUN EDP Services
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- PHUN Technology
- ORMP Health Care
- Exchange
- PHUN Nasdaq
- ORMP Nasdaq
- Market Cap
- PHUN 88.8M
- ORMP 90.7M
- IPO Year
- PHUN N/A
- ORMP N/A
- Fundamental
- Price
- PHUN $3.65
- ORMP $2.61
- Analyst Decision
- PHUN Strong Buy
- ORMP Hold
- Analyst Count
- PHUN 3
- ORMP 1
- Target Price
- PHUN $13.00
- ORMP N/A
- AVG Volume (30 Days)
- PHUN 1.4M
- ORMP 415.7K
- Earning Date
- PHUN 03-11-2025
- ORMP 03-05-2025
- Dividend Yield
- PHUN N/A
- ORMP N/A
- EPS Growth
- PHUN N/A
- ORMP N/A
- EPS
- PHUN N/A
- ORMP 0.11
- Revenue
- PHUN $3,537,000.00
- ORMP N/A
- Revenue This Year
- PHUN N/A
- ORMP N/A
- Revenue Next Year
- PHUN $93.33
- ORMP N/A
- P/E Ratio
- PHUN N/A
- ORMP $23.75
- Revenue Growth
- PHUN N/A
- ORMP N/A
- 52 Week Low
- PHUN $2.85
- ORMP $2.00
- 52 Week High
- PHUN $17.99
- ORMP $3.67
- Technical
- Relative Strength Index (RSI)
- PHUN 38.74
- ORMP 36.05
- Support Level
- PHUN $3.71
- ORMP $2.12
- Resistance Level
- PHUN $4.04
- ORMP $2.27
- Average True Range (ATR)
- PHUN 0.27
- ORMP 0.07
- MACD
- PHUN -0.06
- ORMP -0.01
- Stochastic Oscillator
- PHUN 14.28
- ORMP 22.73
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.